The factors that govern the progression from colonic adenomatous polyp to colon cancer are poorly understood. The observation that NSAIDs act as chemopreventative agents and reduce the size of colonic polyps suggests the involvement of in¯ammatory signalling, but in¯ammatory signalling in colonic polyps has not been studied. We investigated the expression of the active forms of NF-kB, JNK and p38 MAPK using immunohistochemistry with activation speci®c antibodies in human colonic adenomas. We show that active NF-kB is seen in stromal macrophages that also express COX-2 and TNF-a, active JNK is seen in stromal and intraepithelial T-lymphocytes and periendothelial cells of new blood vessels, and active p38 MAPK is most highly expressed in macrophages and other stromal cells. These results demonstrate the presence of active in¯ammatory signal transduction in colonic polyps and that these are predominantly in the stroma. In the case of NF-kB this coincides with the cellular localisation of COX-2. These results support evidence that NSAIDs may act through eects on stromal cells rather than epithelial cells. Oncogene (2001) 20, 819 ± 827.
Introduction
Non Steroidal Anti In¯ammatory Drugs (NSAIDs) and other anti-in¯ammatory compounds such as Curcumin act as chemopreventative agents in colon cancer (Janne and Mayer, 2000; Plummer et al., 1999) . This suggests a role for in¯ammation and in¯amma-tory pathways in the progression of colon cancer. Surprisingly, the activity of in¯ammatory signal transduction pathways has not been studied in colon cancer. In this study we set out to investigate the sitespeci®c activity of Nuclear Factor Kappa B (NF-kB), p38 Mitogen Activated Protein Kinase (p38 MAPK), and cJun NH 2 terminal kinase (JNK) in human colonic polyps. They are all components of signal transduction pathways that play pivotal roles in in¯ammation (Mercurio and Manning, 1999; Ono and Han, 2000; Ip and Davis, 1998) . That molecules within these pathways may also provide direct targets for NSAIDs and are important in regulating cell proliferation and apoptosis, makes the characterisation of their expression in colon cancer all the more interesting.
NSAIDs are thought to prevent colon cancer by their actions on Cyclooxygenase enzyme type 2 (COX-2). Mice treated with speci®c COX-2 inhibitors or bred to be genetically de®cient in COX-2 develop dramatically fewer colon tumours than their littermates in a mouse model of familial adenomatous polyposis (APC D716 mice) (Oshima et al., 1996) and over expression of COX-2 in intestinal epithelial cells leads to enhanced tumourigenic phenotypes, metastatic potential and angiogenesis (Tsujii and DuBois, 1995; Tsujii et al., 1997 Tsujii et al., , 1998 . However, there is increasing evidence that NSAIDs have important COX independent eects both in their action as chemopreventative agents (Chiu et al., 1997; Bak et al., 1998; Piazza et al., 1997) , and as anti-in¯amma-tory agents. Several studies have shown speci®c inhibition of I kappa B kinase beta leading to inhibition of NF-kB thus interfering with the transcription of in¯ammatory cytokines (Kopp and Ghosh, 1994; Yin et al., 1998) . This ®nding, together with the knowledge that NF-kB plays an important role in apoptosis, has led many to list NF-kB as a possible COX independent mechanism for the action of NSAIDs in colon cancer (Janne and Mayer, 2000) . Others have found that Salicylates promote apoptosis via a p38 MAPK dependant mechanism (Schwenger et al., 1997) and may also activate JNK (Schwenger et al., 1999) .
The expression of JNK in colon cancer has already received some attention (Licato and Brenner, 1998; Licato et al., 1997) . The authors of these studies found increased activity of JNK in both rat models of colon cancer as well as human tumours. However their data comes from homogenates of tumour tissue as thus gives no indication as to where in the tumour these molecules are expressed and therefore less information as to how they might be important in the biology of colon cancer.
We performed immunohistochemistry using antibodies speci®c to the active forms of these proteins to identify which pathways are active in the polyps, and identify in which cells these pathways are active. This approach has only relatively recently become feasible with the advent of reliable`phospho-speci®c' antibodies to signalling pathway components, and other antibodies that are highly speci®c to the active forms of these proteins.
We used immunohistochemistry as it has the advantage of giving an indication of which cell types within the polyps are expressing the active signalling components. This is particularly important in the light of the developing interest in the role of stromal tissue in colon cancer progression (Hong and Sporn, 1997) .
There is mounting evidence that the stroma, consisting of in®ltrating in¯ammatory cells, new blood vessels and connective tissue cells, plays a vital role in the progression of colon cancer. COX-2 is found by many to be mainly expressed in the stromal tissue of polyps, predominantly in macrophages, both in the polyps of a mouse model of Familial Adenomatous Polyposis (Min mice) (Hull et al., 1999) , and also in human adenomatous polyps (Bamba et al., 1999; Chapple et al., 2000) . In vivo evidence that the antitumour eects of NSAIDs may be brought about through actions on stromal cells rather than on the neoplastic cells comes from an elegant recent study showing that growth of a tumour xenograft was severely inhibited by disruption of host COX-2 production (Williams et al., 2000) . In this model all the stromal cells are provided by the host, and a pure culture of tumour cells are injected as a xenograft. Thus it is of great importance to show in which cells molecules implicated in cancer progression are expressed, and not to rely solely on data from tissue homogenates.
Results

Active NF-kB is seen mainly in stromal macrophages
Strong staining with anti-active NF-kB is seen in mainly in stromal cells within human colonic polyps. Figure 1 shows that these stromal cells are CD68 positive cells as seen in sequential sections (Figure 1a and b) and double stained sections (Figure 1c ). These macrophages are situated both super®cially in the lamina propria where they form aggregates in close proximity to capillaries, and also in the stroma deeper within the polyps where they are more widely and evenly spaced. The super®cial aggregates are not seen in the normal tissue specimens, although normal specimens do have similar numbers of deep macrophages (Figure 1d ).
Active NF-kB and COX-2 enzyme are expressed in the same cells COX-2 enzyme has been recently shown to be predominantly expressed in super®cial macrophages in colonic polyps. We therefore decided to investigate whether there was any overlap between COX-2 and active NF-kB expression. Using staining in sequential sections we observed a very close pattern of expression of the two molecules. Figure 2 shows that active NFkB (Figure 2a and c) is seen in the nuclei of the same cells that express COX-2 (Figure 2b and d) , as judged from staining of sequential sections. Double staining methods were not used because the two antibodies are both mouse monoclonal antibodies of the same IgG subclass and thus dicult to distinguish with secondary antibodies.
Active NF-kB and TNF alpha are expressed in the same cells An established method to con®rm that the active NFkB antibody staining is speci®c is to look for expression of TNF-a (van Den Brink et al., 2000) . TNF-a both leads to NF-kB activation and is itself transcriptionally upregulated by active NF-kB. We show a close overlap of TNF-a and NF-kB expression in sequential sections in Figure 3 , and that both these molecules are predominantly active in CD68 positive macrophages.
Phosphorylated JNK is seen mainly in stromal T-lymphocytes and periendothelial cells
Staining with Phospho-JNK antibodies is shown in Figure 4 . Strong staining is localised to the polyp stromal tissue (Figure 4a ). Morphologically this appeared to be largely in T-lymphocytes and intraepithelial T-lymphocytes. Staining of serial sections ( Figure 4c and d) showed a strong overlap between CD3 and pJNK staining and double staining ( Figure  4e and f) con®rmed that pJNK is predominantly found in stromal T-lymphocyes and intraepithelial T-lymphocytes. There was also strong staining of cells surrounding the microvasculature of the polyp. CD31 staining showed that these were cells lying outside endothelial cells, the periendothelial cells or pericytes (not shown). There were signi®cantly larger numbers of T-lymphocytes in®ltrating the colonic polyps compared to normal tissue (212; 95% CI 226 ± 198 vs 48; 95% CI 36 ± 60) as judged by counting CD3 positive cells. This dierence largely accounts for the higher pJNK expression seen in polyps versus normal tissue ( Figure  4b ).
Phosphorylated p38 MAP kinase is most highly expressed in the stroma
Phosphorylated p38 MAP kinase (pp38 MAPK) stains most strongly in the stroma. Here, as seen in Figure 5 , staining of sequential sections with CD68 shows that some of these stromal cells are macrophages and that areas of stroma expressing high levels of pp38 MAPK are those where there are large numbers of CD68 positive macrophages. However, not all the pp38 MAPK positive cells are CD68 positive macrophages.
Other stromal cell types also express pp38 MAPK, and there is also low-level expression in epithelial cells. Normal colonic tissue shows a similar pattern of staining but the levels are lower and there are no super®cial aggregates of macrophages and fewer in¯ammatory cells in general ( Figure 5c ).
Discussion
The evidence that non-steroidal anti-in¯ammatory drugs (NSAIDs), such as Aspirin, prevent colon cancer (Thun et al., 1991) provides a rational starting point for investigation into the molecular biology of colon cancer. These anti-in¯ammatory agents exert many of their eects through the inhibition of the enzymes COX-1 and 2 therefore research into their chemopreventative eects has also focussed heavily on these enzymes, resulting in powerful evidence that NSAIDs prevent colon cancer by inhibiting COX. However there are several ®ndings that suggest that COX may not be the only answer. Sulindac Sulfone, with no appreciable COX inhibiting activity nevertheless retains its antitumour activity (Charalambous and O'Brien, 1996) and NSAIDs are equally active in killing the COX de®cient human colon cancer cell line HCT-15 as COX expressing colon cancer cell lines (Hanif et al., 1996) ; a ®nding that is supported by recent experiments in COX-1 and COX-2 negative mouse ®broblasts (Zhang et al., 1999) .
If all NSAIDs are active in colon cancer regardless of COX inhibiting activity, this suggests that the eect Figure 1 Immunohistochemistry for active NF-kappaB in human sporadic colonic adenomas. Strong staining for active NF-kB is seen localised to aggregates of super®cial stromal cells as well as stromal cells deeper within the polyps (a). These cells are macrophages as determined by morphology and by CD68 (a macrophage marker) staining in sequential sections (b) and lie in close proximity to capillaries. This was further con®rmed by performing active NF-kB (blue) and CD68 (red) double staining (c). Normal colonic tissue (d) shows similar active NF-kB staining of deep macrophages but does not contain the super®cial aggregates of macrophages. Throughout all immunohistochemistry control staining was consistently negative. An example performed by omitting the primary antibody (e) is shown Figure 2 Immunohistochemistry for active NF-kB (a+c) and COX-2 (b+d) in human sporadic colonic polyps. A remarkable degree of overlap was seen between the staining patterns of these two molecules in sequential sections. In the enlargements (c+d) of the areas indicated, cells appearing in both sections that stain positively for both molecules are indicated with arrows Figure 3 Immunohistochemistry for active NF-kB (a+d), TNF-a (b+e) and CD68 (c+f) in human sporadic colonic polyps. Sequential sections were stained for active NF-kB and TNF-a. These two molecules are expressed predominantly in the stroma and both in the same cells within the stroma. These cells are macrophages as shown by the macrophage marker (CD68) staining in a further sequential section (c). In the enlarged sections (d, e and f), white arrows mark cells that stain positively for both active NFkB (d) and TNF-a (e), and black arrows mark one cell that appears across all three sections and another that stains positively for TNF-a (e) and the macrophage marker CD68 (f) is at least partly mediated through an alternative mechanism of action common to all NSAIDs. One obvious unifying feature of NSAIDs is that they are anti-in¯ammatory. Unrelated anti-in¯ammatory compounds such as Curcumin also show activity against colon cancer suggesting the importance of in¯amma-tion and of in¯ammatory molecules and pathways, in colon cancer.
Recent advances in the understanding of the molecular basis of in¯ammation reveal a central role for a relatively small number of intracellular pathways. These signal transduction pathways are well characterised and integrate the combined eects of large numbers of molecules at the cell surface to produce changes in the expression of a large number of genes. The NF-kB, JNK, and p38 MAPK pathways are three important pathways involved with in¯ammation and we hoped that further understanding of their role in colon cancer would be revealing. These same molecules are also implicated in the regulation of apotosis and proliferation of colonic epithelial cells.
There is also evidence linking NF-kB and p38 MAPK more directly to the actions of NSAIDs, and linking JNK with colon cancer. Aspirin, Salicylic acid, Sulindac Sulfone and Curcumin all inhibit NF-kB activation by inhibiting I Kappa B kinase (Kopp and Ghosh, 1994; Yin et al., 1998; Yamamoto et al., 1999; Plummer et al., 1999) . The NF-kB pathway is also involved in the activation of transcription of COX-2. This has led many to list NF-kB as a COXindependent mechanism for the action of NSAIDs in colon cancer. Inhibition of p38 MAPK blocks the Figure 4 Immunohistochemistry for phosphorylated JNK in human sporadic colonic polyps. Strong staining is seen localised to the stromal tissue (a), with no staining in the epithelial cells. Normal colonic tissue (b) shows lower levels of staining, with some stromal in¯ammatory cells staining positively. A close up image of pJNK staining shows strong staining of in¯ammatory cells in®ltrating the polyp (c). Staining of sequential sections for the T-lymphocyte marker CD3 (d) con®rms that these are Tlymphocytes. Cells that appear in both sections and stain positively for both CD3 and pJNK are indicated with arrows (c+d). Double staining for pJNK (blue) and CD3 (red) further con®rms that pJNK is predominantly expressed in T-lymphocytes (e). An enlarged section of image e is shown in image f where pJNK and CD3 localise to the same cells actions of Salicylates on colon cancer cells (Schwenger et al., 1997 (Schwenger et al., , 1998 , and JNK shows greatly enhanced activity in colon cancer in rats (Licato et al., 1997; Licato and Brenner, 1998) .
In this study we set out to determine the site and degree of expression of the active forms of NF-kB, JNK and p38 MAPK using immunohistochemistry in human sporadic colonic adenomas. Immunohistochemistry has the clear advantage of demonstrating which of the various cell types within the adenomas express these elements. Colonic adenomas were used because evidence has shown that these regress in patients treated with NSAIDs (Labayle et al., 1991) . Sporadic adenomas were chosen because they form the vast majority of colonic adenomas (490%) and the magnitude of the reduction in colon cancer deaths attributed to NSAIDs (up to 50%) suggests that these precursors of colon cancer are likely to be NSAID sensitive.
We have demonstrated active NF-kB in interstitial cells in human colonic adenomas. Morphological analysis of the cells suggested that NF-kB localised to macrophages and this was con®rmed using double staining techniques to show that the cells co-express CD68 antigen, a macrophage marker. We show that these same macrophages are also the site of expression of COX-2 and TNF-a. NSAIDs inhibit either COX-2 only (Indomethacin (Yin et al., 1998) ) or NF-kB only (Sulindac Sulfone (Yamamoto et al., 1999) ) or both (Aspirin, Sulindac). These ®ndings suggest that they could be acting on these distinct but related molecules in the same cells. We go on to show that p38 MAPK is active in macrophages in the stroma of polyps. There is evidence that p38 MAPK is involved in the activation of NF-kB in the cytoplasm (Schulze-Ostho et al., 1997) so the ®nding of these two transcription factors both active in macrophages within polyps is not entirely unexpected.
The importance of macrophages in the progression of colon cancer has been suggested by other studies. COX-2 protein is expressed exclusively in macrophages in both normal colon and adenomas of Multiple Intestinal Neoplasia (MIN) mice but is not expressed at all in wild-type littermates (Hull et al., 1999) . In human polyps localisation of COX-2 expression is more controversial. Initial reports showed COX-2 con®ned to neoplastic epithelial cells. However, two recent papers ®nd that the highest expression is in stromal macrophages (Bamba et al., 1999; Chapple et al., 2000) although in advanced cancers expression seems to be in a far wider variety of cell types (Sano et al., 1995) . There have been suggestions in the literature that the stromal staining is non-speci®c cross-reactivity of the polyclonal antibodies when used for immunohistochemistry (Williams et al., 2000) . Our data con®rm, using a dierent, monoclonal COX-2 antibody, that super®cial stromal macrophages are the site of highest expression of COX-2. The ®nding that active NF-kB expression is highest in these same macrophages adds strong supporting evidence that the COX-2 staining is not non-speci®c antibody cross-reactivity, while also add- ing evidence for the speci®city of the active NF-kB antibody.
The speci®city of the antibodies used is obviously of paramount importance. We used TNF-a staining as further evidence for the speci®city of the NF-kB staining because active NF-kB upregulates transcription of TNF-a and NF-kB is activated by TNF-a. We show that immunoreactivity of these two molecules is also seen in macrophages in colonic polyps. The same anti active NF-kB antibody has been used to perform immunohistochemistry in formalin ®xed, paran embedded tissue in other studies including several that have shown activated NF-kB in macrophages (Gaweco et al., 2000; Rogler et al., 1998) . We ourselves have previously shown the speci®city of this antibody under the same conditions by showing colocalisation of TNFa, TRAF-2 and total NF-kB staining with the active NF-kB staining and showing clear nuclear localisation of the active NF-kB (van Den Brink et al., 2000) . Phosphospeci®c antibodies are also increasingly being used in immunohistochemistry in formalin ®xed, paran embedded tissue, especially pJNK and pp38 MAPK (Omori et al., 2000; Pirvola et al., 2000) . Speci®city is usually con®rmed by showing results from immunoblot experiments. These have been performed extensively for the antibodies we have used including con®rmatory kinase assays (Chan et al., 1997; Chen et al., 1998) .
Higher numbers of in®ltrating macrophages are associated with more advanced stage in colon cancer (Hakansson et al., 1997) and expression of the growth factor wnt that lies upstream of the APC/Beta Catenin pathway, the major pathway that is mutated in colon cancer, has also been localised to macrophages within the cancer stroma (Smith et al., 1999) . The authors of these studies suggest that macrophages may have a paracrine eect possibly by suppressing the activity of other cytotoxic immune cells, or by the direct eect of the cytokines they secrete on the epithelial cells.
The importance of in®ltrating lymphocytes in colon cancer has long been appreciated since higher numbers of in®ltrating lymphocytes are associated with a more favourable outcome (Svennevig et al., 1984; Di Giorgio et al., 1992) . This has led to extensive eorts towards immunotherapy for colon cancer. The ®nding of high expression of pJNK in T-lymphocytes in®ltrating the polyp stroma is interesting because the kinase activity of JNK has been found to be dramatically increased in colon carcinomas (Licato et al., 1997) . JNK is one of the major kinases activating the transcription factor complex AP-1 that plays an important role in neoplastic transformation (Karin et al., 1997) .
The importance of stromal cells in general is also receiving more attention. The stroma is felt to have reciprocal interactions with its overlying epithelial cells with each aecting the proliferation and dierentiation of the other (Hong and Sporn, 1997) . Our ®ndings of activation of pivotal elements in pathways central to in¯ammation and carcinogenesis mainly con®ned to the stroma may add further credence to this hypothesis.
Materials and methods
The ten most recent cases of adenomatous polyp removed at colonoscopy, together with normal biopsies from the same patients, where these existed, were taken from the archives of the Pathology Department at the AMC. Four mm sections were prepared from the formalin ®xed, paran embedded tissue and mounted on slides coated with polylysin. We took polyps rather than cancer specimens because evidence points towards NSAIDs exerting their eects during this relatively lengthy period in the progression of cancer. We took sporadic polyps by excluding specimens from patients with FAP and with Hereditary Non-Polyposis Coli (HNPCC) as we reasoned that in order for NSAIDs to have the magnitude of eect that has been observed they must act on these polyps, which comprise well over 90% of cases. 
Secondary antibodies
Goat anti-mouse antibodies and Goat anti-Rabbit antibodies conjugated with biotin or Alkaline Phosphatase depending on detection mechanism (all from DAKO).
Immunohistochemistry: Single stainings
Sections were dewaxed and rehydrated in graded alcohols. Immunohistochemistry: Double stainings NF-kB and pJNK double staining with CD68 and CD3 respectively, required the initial staining to be on the sections with no prior use of an antigen retrieval method. After the ®rst staining the same sections were then digested with 0.25% Pepsin in 0.01 M HCl at 378C for 15 min followed by washing (365 min in PBS), before proceeding with the second staining. For the blue b-galactosidase staining biotinylated secondary antibodies were used and sections were then incubated with streptavidin b-galactosidase (1 : 40, Boehringer Mannheim) at room temperature for 30 min. Detection was with 1% X-gal (DAKO) in iron phosphate buer (0.02% MgCl 2´6 H 2 O, 0.099% potassium ferricyanide, 0.127% potassium ferrocyanide) at 378C for 15 min. For the`Fast Red' detection method (DAKO) alkaline phosphatase conjugated secondary antibodies were used and after washing in Tris-buered saline, the alkaline phosphatase was detected using the`Fast Red' detection method. Double-stained sections were mounted in Ultramount (DAKO).
Counting of lymphocyte numbers in all specimens
Five digital pictures were taken at 2006magni®cation from random areas of slides prepared from each of the ten polyp specimens and from the six specimens of normal tissue stained with anti-CD3. These were scored blindly using image analysis software.
